Recruiting Waldenstrom Macroglobulinemia Studies in Centralia
About Waldenstrom Macroglobulinemia Clinical Trials in Centralia
Waldenstrom macroglobulinemia is a rare type of non-Hodgkin lymphoma where cancer cells produce large amounts of an abnormal protein called macroglobulin. It progresses slowly and may not require immediate treatment. Options include targeted therapy, chemotherapy, and plasmapheresis.
There are currently 1 waldenstrom macroglobulinemia clinical trials recruiting participants in Centralia, IL. These studies are seeking a combined 92 participants. Research is being sponsored by National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.
Waldenstrom Macroglobulinemia Clinical Trials in Centralia — FAQ
Are there waldenstrom macroglobulinemia clinical trials in Centralia?
Yes, there are 1 waldenstrom macroglobulinemia clinical trials currently recruiting in Centralia, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Centralia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Centralia research site will contact you about next steps.
Are clinical trials in Centralia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Centralia studies also compensate for your time and travel.
What waldenstrom macroglobulinemia treatments are being tested?
The 1 active trials in Centralia are testing new therapies including novel drugs, biologics, and treatment approaches for waldenstrom macroglobulinemia.
Data updated March 2, 2026 from ClinicalTrials.gov